[1]O’Malley CD, Shaw GM, Wasserman CR, Lammer EJ. Epidemiologic characteristics of conotruncal heart defects in California, 1987–1988. Teratology. 1996. 53(6): 374–7.
[2]Müller AM, Sarioglu N. [Congenital heart defects of the septa, endocardial cushions and the conotruncus]. Pathologe. 2012. 33(3): 205–16.
[3]Li B, Pu T, Liu Y, Xu Y, Xu R. CITED2 Mutations in Conserved Regions Contribute to Conotruncal Heart Defects in Chinese Children. DNA Cell Biol. 2017. 36(7): 589–595.
[4]Tomita-Mitchell A, Maslen CL, Morris CD, Garg V, Goldmuntz E. GATA4 sequence variants in patients with congenital heart disease. J Med Genet. 2007. 44(12): 779–83.
[5]Chen M, Yang YS, Shih JC, et al. Microdeletions/duplications involving TBX1 gene in fetuses with conotruncal heart defects which are negative for 22q11.2 deletion on fluorescence in-situ hybridization. Ultrasound Obstet Gynecol. 2014. 43(4): 396–403.
[6]De Luca A, Sarkozy A, Ferese R, et al. New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle. Clin Genet. 2011. 80(2): 184–90.
[7]Zhang E, Hong N, Chen S, et al. Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects. Gene. 2018. 641: 341–348.
[8]Antshel KM, Kates WR, Roizen N, Fremont W, Shprintzen RJ. 22q11.2 deletion syndrome: genetics, neuroanatomy and cognitive/behavioral features keywords. Child Neuropsychol. 2005. 11(1): 5–19.
[9]Barber JC, Rosenfeld JA, Foulds N, et al. 8p23.1 duplication syndrome; common, confirmed, and novel features in six further patients. Am J Med Genet A. 2013. 161A(3): 487–500.
[10]Marino B, Digilio MC. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol. 2000. 9(6): 303–15.
[11]Griffin HR, Töpf A, Glen E, et al. Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart. 2010. 96(20): 1651–5.
[12]Soemedi R, Wilson IJ, Bentham J, et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet. 2012. 91(3): 489–501.
[13]Bauer RC, Laney AO, Smith R, et al. Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat. 2010. 31(5): 594–601.
[14]Molkentin JD, Jobe SM, Markham BE. Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. J Mol Cell Cardiol. 1996. 28(6): 1211–25.
[15]Croissant JD, Kim JH, Eichele G, et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev Biol. 1996. 177(1): 250–64.
[16]Belaguli NS, Sepulveda JL, Nigam V, Charron F, Nemer M, Schwartz RJ. Cardiac tissue enriched factors serum response factor and GATA–4 are mutual coregulators. Mol Cell Biol. 2000. 20(20): 7550–8.
[17]Huang WY, Chen JJ, Shih N, Liew CC. Multiple muscle-specific regulatory elements are associated with a DNase I hypersensitive site of the cardiac beta-myosin heavy-chain gene. Biochem J. 1997. 327 ( Pt 2): 507–12.
[18]Gupta M, Kogut P, Davis FJ, Belaguli NS, Schwartz RJ, Gupta MP. Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor–1. J Biol Chem. 2001. 276(13): 10413–22.
[19]Chen CY, Schwartz RJ. Recruitment of the tinman homolog Nkx–2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol Cell Biol. 1996. 16(11): 6372–84.
[20]Morin S, Paradis P, Aries A, Nemer M. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol Cell Biol. 2001. 21(4): 1036–44.
[21]Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003. 35(6): 577–93.
[22]Huang J, Elicker J, Bowens N, et al. Myocardin regulates BMP10 expression and is required for heart development. J Clin Invest. 2012. 122(10): 3678–91.
[23]Mokalled MH, Carroll KJ, Cenik BK, et al. Myocardin-related transcription factors are required for cardiac development and function. Dev Biol. 2015. 406(2): 109–16.
[24]Belaguli NS, Schildmeyer LA, Schwartz RJ. Organization and myogenic restricted expression of the murine serum response factor gene. A role for autoregulation. J Biol Chem. 1997. 272(29): 18222–31.
[25]Niu Z, Yu W, Zhang SX, et al. Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets. J Biol Chem. 2005. 280(37): 32531–8.
[26]Pu T, Liu Y, Xu R, Li F, Chen S, Sun K. Identification of ZFPM2 mutations in sporadic conotruncal heart defect patients. Mol Genet Genomics. 2018. 293(1): 217–223.
[27]Pareek CS, Smoczynski R, Tretyn A. Sequencing technologies and genome sequencing. J Appl Genet. 2011. 52(4): 413–35.
[28]McBride K, Nemer M. Regulation of the ANF and BNP promoters by GATA factors: lessons learned for cardiac transcription. Can J Physiol Pharmacol. 2001. 79(8): 673–81.
[29]McGrath J, Somlo S, Makova S, Tian X, Brueckner M. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell. 2003. 114(1): 61–73.
[30]Janknecht R, Ernst WH, Houthaeve T, Nordheim A. C-terminal phosphorylation of the serum-response factor. Eur J Biochem. 1993. 216(2): 469–75.
[31]Small EM, Krieg PA. Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2–5 and GATA–4 binding sites are required for atrial specific expression of ANF. Dev Biol. 2003. 261(1): 116–31.
[32]Spencer JA, Misra RP. Expression of the serum response factor gene is regulated by serum response factor binding sites. J Biol Chem. 1996. 271(28): 16535–43.
[33]Ward C, Stadt H, Hutson M, Kirby ML. Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. Dev Biol. 2005. 284(1): 72–83.
[34]Hutson MR, Kirby ML. Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin Cell Dev Biol. 2007. 18(1): 101–10.
[35]Waldo KL, Hutson MR, Ward CC, et al. Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart. Dev Biol. 2005. 281(1): 78–90.
[36]Nakajima Y. Second lineage of heart forming region provides new understanding of conotruncal heart defects. Congenit Anom (Kyoto). 2010. 50(1): 8–14.
[37]McCulley DJ, Black BL. Transcription factor pathways and congenital heart disease. Curr Top Dev Biol. 2012. 100: 253–77.
[38]Unolt M, Putotto C, Silvestri LM, et al. Transposition of great arteries: new insights into the pathogenesis. Front Pediatr. 2013. 1: 11.
[39]Muscat GE, Gustafson TA, Kedes L. A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle. Mol Cell Biol. 1988. 8(10): 4120–33.
[40]Zhang X, Chai J, Azhar G, et al. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem. 2001. 276(43): 40033–40.
[41]Miano JM, Ramanan N, Georger MA, et al. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A. 2004. 101(49): 17132–7.
[42]Parlakian A, Tuil D, Hamard G, et al. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol. 2004. 24(12): 5281–9.
[43]Nelson TJ, Balza R, Xiao Q, Misra RP. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol. 2005. 39(3): 479–89.
[44]Boheler KR, Chassagne C, Martin X, Wisnewsky C, Schwartz K. Cardiac expressions of alpha- and beta-myosin heavy chains and sarcomeric alpha-actins are regulated through transcriptional mechanisms. Results from nuclear run-on assays in isolated rat cardiac nuclei. J Biol Chem. 1992. 267(18): 12979–85.
[45]Gustafson TA, Bahl JJ, Markham BE, Roeske WR, Morkin E. Hormonal regulation of myosin heavy chain and alpha-actin gene expression in cultured fetal rat heart myocytes. J Biol Chem. 1987. 262(27): 13316–22.
[46]Ren X, Philipson KD. The topology of the cardiac Na⁺/Ca²⁺ exchanger, NCX1. J Mol Cell Cardiol. 2013. 57: 68–71.
[47]Argentin S, Ardati A, Tremblay S, et al. Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol Cell Biol. 1994. 14(1): 777–90.
[48]Zeisberg EM, Ma Q, Juraszek AL, et al. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest. 2005. 115(6): 1522–31.
[49]Sepulveda JL, Vlahopoulos S, Iyer D, Belaguli N, Schwartz RJ. Combinatorial expression of GATA4, Nkx2–5, and serum response factor directs early cardiac gene activity. J Biol Chem. 2002. 277(28): 25775–82.
[50]Christoforou N, Chellappan M, Adler AF, et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One. 2013. 8(5): e63577.
[51]Schueler M, Zhang Q, Schlesinger J, Tönjes M, Sperling SR. Dynamics of Srf, p300 and histone modifications during cardiac maturation in mouse. Mol Biosyst. 2012. 8(2): 495–503.
[52]Niu Z, Li A, Zhang SX, Schwartz RJ. Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol. 2007. 19(6): 618–27.
[53]Shaw PE, Frasch S, Nordheim A. Repression of c-fos transcription is mediated through p67SRF bound to the SRE. EMBO J. 1989. 8(9): 2567–74.